105 related articles for article (PubMed ID: 26105798)
21. Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis.
van de Water W; Bastiaannet E; Dekkers OM; de Craen AJ; Westendorp RG; Voogd AC; van de Velde CJ; Liefers GJ
Br J Surg; 2012 Jun; 99(6):813-20. PubMed ID: 22492310
[TBL] [Abstract][Full Text] [Related]
22. Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients?
Varga D; Wischnewsky M; Atassi Z; Wolters R; Geyer V; Strunz K; Kreienberg R; Woeckel A
Oncology; 2010; 78(3-4):189-95. PubMed ID: 20414007
[TBL] [Abstract][Full Text] [Related]
23. In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study.
Frandsen J; Ly D; Cannon G; Suneja G; Matsen C; Gaffney DK; Wright M; Kokeny KE; Poppe MM
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1096-103. PubMed ID: 26581146
[TBL] [Abstract][Full Text] [Related]
24. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
25. The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients.
Jacke CO; Albert US; Kalder M
BMC Cancer; 2015 Oct; 15():734. PubMed ID: 26481452
[TBL] [Abstract][Full Text] [Related]
26. Moderate level of HER2 expression and its prognostic significance in breast cancer with intermediate grade.
Ignatov T; Eggemann H; Burger E; Fettke F; Costa SD; Ignatov A
Breast Cancer Res Treat; 2015 Jun; 151(2):357-64. PubMed ID: 25926338
[TBL] [Abstract][Full Text] [Related]
27. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
28. Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a,b) - results from the Munich Cancer Registry.
Kolben T; Harbeck N; Wuerstlein R; Schubert-Fritschle G; Bauerfeind I; Schrodi S; Engel J
Breast; 2015 Feb; 24(1):24-31. PubMed ID: 25543874
[TBL] [Abstract][Full Text] [Related]
29. Time trends in the outcome of elderly patients with breast cancer.
Hughes S; Barbachano Y; Ashley S; Yap YS; Popat S; Allen M; Della-Rovere UQ; Johnston S; Smith I; O'Brien M
Breast J; 2008; 14(2):158-63. PubMed ID: 18312470
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
Coleman R; Cameron D; Dodwell D; Bell R; Wilson C; Rathbone E; Keane M; Gil M; Burkinshaw R; Grieve R; Barrett-Lee P; Ritchie D; Liversedge V; Hinsley S; Marshall H;
Lancet Oncol; 2014 Aug; 15(9):997-1006. PubMed ID: 25035292
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
32. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
33. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
34. Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
Somlo G; Frankel P; Chow W; Leong L; Margolin K; Morgan R; Shibata S; Chu P; Forman S; Lim D; Twardowski P; Weitzel J; Alvarnas J; Kogut N; Schriber J; Fermin E; Yen Y; Damon L; Doroshow JH
J Clin Oncol; 2004 May; 22(10):1839-48. PubMed ID: 15143076
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
[TBL] [Abstract][Full Text] [Related]
36. Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9,156 patients.
Schwentner L; Wöckel A; König J; Janni W; Ebner F; Blettner M; Kreienberg R; Van Ewijk R;
BMC Cancer; 2013 Oct; 13():487. PubMed ID: 24138748
[TBL] [Abstract][Full Text] [Related]
37. [Symptom-oriented follow-up of early breast cancer compared to intensive surveillance. Results of a prospective multicentre study: update and 10-year overall survival].
Bornhak S; Heidemann E; Meisner C; Herschlein HJ; Simon W; Merkle E; Schmidt B; Metzger H; Rössle S; Brinkmann F
Dtsch Med Wochenschr; 2012 Oct; 137(42):2142-8. PubMed ID: 23055354
[TBL] [Abstract][Full Text] [Related]
38. Comparison of early onset breast cancer patients to older premenopausal breast cancer patients.
Varga D; Koenig J; Kuhr K; Strunz K; Geyer V; Kurzeder C; Atassi Z; Blettner M; Kreienberg R; Woeckel A
Arch Gynecol Obstet; 2010 Oct; 282(4):427-32. PubMed ID: 20047053
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for male breast cancer: similarity to female counterparts.
Yu E; Stitt L; Vujovic O; Joseph K; Assouline A; Au J; Younus J; Perera F; Tai P
Anticancer Res; 2013 May; 33(5):2227-31. PubMed ID: 23645780
[TBL] [Abstract][Full Text] [Related]
40. Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.
Hou G; Zhang S; Zhang X; Wang P; Hao X; Zhang J
Breast Cancer Res Treat; 2013 Feb; 137(3):807-16. PubMed ID: 23292119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
